(Q81828300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

Barzin Khalili

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Peter B Boggs

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Runhua Shi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Sami L Bahna

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

124-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

Asthma. From bronchoconstriction to airways inflammation and remodeling

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Development and validation of a questionnaire to measure asthma control.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Development of the asthma control test: a survey for assessing asthma control

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Attaining optimal asthma control: a practice parameter

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Does bronchial hyperresponsiveness in asthma matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Exhaled nitric oxide correlates with airway eosinophils in childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Reliability of a new hand-held device for the measurement of exhaled nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Respiratory nitric oxide levels in experimental human influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Acute and chronic effects of cigarette smoking on exhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Increased nitric oxide in exhaled air after intake of a nitrate-rich meal

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Development and cross-sectional validation of the Childhood Asthma Control Test

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Impaired Perception of Dyspnea in Patients with Severe Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Exhaled nitric oxide predicts asthma exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Use of exhaled nitric oxide measurements to guide treatment in chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Exhaled nitric oxide levels correlate with measures of disease control in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Irreversible lung function deficits in young adults with a history of childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

Effect of inhaled steroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960199-8

7 January 2021

10.1016/S1081-1206(10)60199-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18727466%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference